ADARx Pharmaceuticals, Inc. (ADRX)
12.67
-1.49
(-10.52%)
USD |
NASDAQ |
Nov 20, 16:00
12.67
0.00 (0.00%)
After-Hours: 16:05
ADARx Pharmaceuticals Total Assets (Quarterly) : 929.06M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 929.06M |
| June 30, 2026 | 456.33M |
| Date | Value |
|---|---|
| March 31, 2026 | 482.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 462.08M |
| IRulya Therapeutics, Inc. | 106.47M |
| PepGen Inc. | 127.78M |
| Q32 Bio, Inc. | 297.20M |
| Bridgebio Oncology Therapeutics, Inc. | 346.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 354.66M |
| Shareholders Equity (Quarterly) | 574.40M |
| Debt to Equity Ratio | 0.0112 |
| Current Ratio | 21.08 |
| Net Debt Paydown Yield | -0.03% |